UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062464
Receipt number R000070674
Scientific Title Artificial Intelligence-assisted Measurement of Cardiac Output via Non-invasive Image Technology During Passive Leg Raising Testing (AI-MONITOR): A Prospective Observational Study
Date of disclosure of the study information 2026/08/26
Last modified on 2026/08/26 13:42:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Artificial Intelligence-assisted Measurement of Cardiac Output via Non-invasive Image Technology During Passive Leg Raising Testing (AI-MONITOR): A Prospective Observational Study

Acronym

AI-MONITOR study

Scientific Title

Artificial Intelligence-assisted Measurement of Cardiac Output via Non-invasive Image Technology During Passive Leg Raising Testing (AI-MONITOR): A Prospective Observational Study

Scientific Title:Acronym

AI-MONITOR study

Region

Japan


Condition

Condition

Patients admitted to the intensive care unit (ICU) of Fukushima Medical University Hospital who were monitored with the FloTrac system and underwent passive leg raising (PLR) testing.

Classification by specialty

Anesthesiology Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to validate an artificial intelligence (AI)-based method for geometrically extracting arterial pressure waveform area ratios from photographs of physiological monitor screens acquired using a smartphone. Specifically, the study aims to determine how accurately stroke volume (SV) and cardiac output (CO) changes derived from these area ratios reflect hemodynamic changes induced by passive leg raising (PLR).

The FloTrac system, a continuous cardiac output monitoring device, will be used as the reference method. This study will evaluate the accuracy and feasibility of the proposed approach as a novel hemodynamic assessment tool that does not require specialized equipment and can be applied in a real-world intensive care unit (ICU) setting.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Agreement and error (Bland Altman analysis) between changes in stroke volume (delta SV) derived from ChatGPT based analysis of arterial pressure waveform area ratios (AI method) and delta SV measured by the FloTrac system (FT method) during passive leg raising (PLR).

Key secondary outcomes

a) Comparison of the percent changes in SV and CO calculated by the AI method and the FT method during the transition from the head-down to the head-up position (Bland-Altman analysis)

b) Sensitivity, specificity, and area under the curve (AUC) using delta SV calculated by the AI method as a continuous variable, defining fluid responsiveness (gold standard) as a more than 10% increase in delta SV measured by the FT method

c) Trend concordance rate of delta SV and delta CO between the AI and FT methods during two sequential postural changes (head-up to head-down to head-up), assessed by four-quadrant plot analysis

d) Feasibility (analysis success rate) of the proposed method (smartphone recording and AI image analysis) and classification of reasons for unanalyzable cases (e.g., light reflection, extreme camera shake, AI recognition errors, and waveform irregularities due to arrhythmias)

The following will be performed as exploratory analyses:

e) Comparison of delta SV and delta CO calculated using As/Ad and Pmd extracted by three different prompts in the AI method

f) Similar evaluation of the above using Gemini, and comparison of the results between ChatGPT and Gemini


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients aged 18 years or older who meet either of the following criteria will be eligible for inclusion:
Patients admitted to the intensive care unit (ICU) of Fukushima Medical University Hospital between Aug 2026 and December 2028 who were monitored with the FloTrac system and underwent passive leg raising (PLR) testing.

Key exclusion criteria

Data from patients or time points meeting any of the following criteria will be excluded:

1. Passive leg raising (PLR) tests performed in the presence of cardiac arrhythmias.

2. Patients receiving mechanical circulatory support (e.g., extracorporeal membrane oxygenation [ECMO]).

3. Patients in whom interpretation of the PLR test is considered difficult, or in whom the reliability of hemodynamic measurements obtained from the FloTrac system or pulmonary artery catheter (PAC) is considered inadequate.

Target sample size

84


Research contact person

Name of lead principal investigator

1st name Keisuke
Middle name
Last name Yoshida

Organization

Fukushima Medical University

Division name

Department of Anesthesiology

Zip code

9601295

Address

1-Hikarigaoka, Fukushima, Fukushima, Japan

TEL

0245471342

Email

kei-y7of@fmu.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name
Last name Yoshida

Organization

Fukushima Medical University

Division name

Department of Anesthesiology

Zip code

9601295

Address

1, Hikarigaoka, Fukushima, Fuksuhima, Japan

TEL

0245471342

Homepage URL


Email

kei-y7of@fmu.ac.jp


Sponsor or person

Institute

Fukushima Medical University

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Fukushima Medical University

Address

1, Hikarigaoka, Fukushima, Fukushima, Japan

Tel

0245471825

Email

rs@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 07 Month 11 Day

Date of IRB

2026 Year 08 Month 24 Day

Anticipated trial start date

2026 Year 09 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

ICU management will be performed according to the standard practice at our institution. Upon ICU admission, all patients are routinely monitored using standard monitoring devices including an arterial catheter. Among them, patients for whom continuous cardiac output monitoring is considered clinically appropriate will be monitored using the FloTrac system (for postoperative patients, the system is typically initiated in the operating room).

During ICU stay, the following data will be collected and analyzed:

- Patient characteristics: age, sex, height, weight, diagnosis (or surgical procedure in postoperative patients), comorbidities, and use of vasoactive agents.
- Severity of illness: Sequential Organ Failure Assessment (SOFA) score and Acute Physiology and Chronic Health Evaluation II (APACHE II) score.
- Details of each passive leg raising (PLR) test, including date, time, vasoactive medications, and fluid administration status.
- FloTrac system data obtained during PLR testing: stroke volume (SV), cardiac output (CO), stroke volume variation (SVV), systemic vascular resistance (SVR), and central venous pressure (CVP), when available.
- Photographs of the physiological monitor obtained using a smartphone before and after PLR testing, including blood pressure, heart rate, and CVP when available.


Management information

Registered date

2026 Year 08 Month 04 Day

Last modified on

2026 Year 08 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070674